A randomized, double-blind study comparing multiple doses of Channa striatus supplementation for knee osteoarthritis

被引:4
作者
Azidah A.K. [1 ,2 ]
Arifah A.K. [3 ]
Roslida A.H. [4 ]
Mat Jais A.M. [4 ,5 ]
Omar J. [6 ]
Sadagatullah A.N. [7 ]
Ishak A. [2 ]
Mohd. Noor N. [2 ]
Musa A.T. [8 ]
机构
[1] Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Universiti Putra Malaysia, Serdang, Selangor
[2] Department of Family Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan
[3] Department of Veterinary Pre Clinical Sciences, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, 43400, Selangor Darul Ehsan
[4] Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 43400, Selangor
[5] Abmanan Biomedical Sdn Bhd (ABSB), A-G-1, Univ 360 Place, Jalan Raya 2, Taman Serdang Raya, Seri Serdang, 43300, Selangor
[6] Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan
[7] Department of Orthopedic, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan
[8] Department of Radiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan
来源
Oriental Pharmacy and Experimental Medicine | 2017年 / 17卷 / 4期
关键词
Arthritis; Biomarker; Channa Striatus; Complementary; Osteoarthritis;
D O I
10.1007/s13596-017-0293-7
中图分类号
学科分类号
摘要
Knee osteoarthritis (OA) is the leading cause of chronic disability at older age. Channa striatus (CS) is a freshwater fish that is traditionally valued for its medicinal properties in promoting wound healing and reducing post-operative pain. This study evaluate the efficacy of different doses of oral Channa striatus extract on primary knee osteoarthritis patients. A randomized, double-blind, placebo-controlled 3-arm trial was conducted comparing oral CS extract 1000 mg/day or 500 mg/day and placebo among knee OA patients for a 6-month intervention period. The main outcome measures were Western Ontario and McMaster University Osteoarthritis Index (WOMAC), analgesic scores and serum cartilage oligomeric matric protein (COMP). Laboratory-based blood tests were used as safety measures. A total of 120 patients were randomized, and 112 patients were included in the intention-to-treat analysis. Significant reductions in WOMAC stiffness and function scores were achieved at month 6 in CS 1000 mg/day and CS 500 mg/day compared to placebo groups (p < 0.05). No significant differences were found between the groups in terms of analgesic scores, serum COMP and biochemical parameters. No serious adverse events were reported in the study. In conclusion, both doses of CS showed similar efficacy and were more effective than the placebo in treating the symptoms of knee OA. © 2017, Institute of Korean Medicine, Kyung Hee University and Springer Science+Business Media B.V.
引用
收藏
页码:345 / 354
页数:9
相关论文
共 51 条
[1]
Ab Wahab S.Z., Et al., The effect of Channa striatus (Haruan) extract on pain and wound healing of post-lower segment caesarean section women, Evid. Based Complement Alternat Med eCAM 849647, (2015)
[2]
Abadie E., Et al., Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis osteoarthritis and cartilage / OARS, Osteoarthr Res Soc, 12, pp. 263-268, (2004)
[3]
Abu Bakar M.R., Et al., Randomized controlled trial on the effect of Channa striatus extract on measurement of the uterus, Pulsatility index, resistive index of uterine artery and superficial skin wound artery in post lower segment caesarean section women, PLoS One, 10, (2015)
[4]
Al-Saffar F.J., Ganabadi S., Fakurazi S., Response of Channa striatus extract against monosodium Iodoacetate induced osteoarthritis in rats, J Anim Vet Adv, 10, pp. 460-469, (2011)
[5]
Al-Saffar F.J., Ganabadi S., Fakurazi S., Yaakub S., Zerumbone significantly improved immunoreactivity in the synovium compared to Channa striatus extract in monosodium iodoacetate (MIA)- induced knee ostearthritis in rat, J Med Plant Res, 5, pp. 1701-1710, (2011)
[6]
Andersson M.L., Thorstensson C.A., Roos E.M., Petersson I.F., Heinegard D., Saxne T., Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis, BMC Musculoskelet Disord, 7, (2006)
[7]
Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., Christy W., Cooke T.D., Greenwald R., Hochberg M., Et al., Development of criteria for the classification of osteoarthritis. Classification of osteoarthritis of the knee, Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum, 29, 8, pp. 1039-1049, (1986)
[8]
Ausiello J.C., Stafford R.S., Trends in medication use for osteoarthritis treatment, J Rheumatol, 29, pp. 999-1005, (2002)
[9]
Aydin E., Turan Y., Biochemical markers for osteoarthritis: is there any promising candidate? Meandros, Med Dent J, 17, pp. 27-34, (2016)
[10]
Baie S.H., Sheikh K., The wound healing properties of Channa Striatus-cetrimide cream-wound contraction and glycosaminoglycan measurement, J Ethnopharmacol, 73, pp. 15-30, (2000)